Page 8 of Pharma and Healthcare

Q3FY25: Alembic Pharma’s profit dips 23.29 percent to Rs 138.42 crore

The company posted revenue from operations at Rs 1,692.74 crore, up 3.81 per cent as against Rs 1,630.57 crore during…

February 3, 2025 15:50 IST

Budget 2025: Nirmala Sitharaman announces plan to add 75,000 seats in medical colleges and hospitals

Budget 2025: The FM also announced 10,000 fellowships will be provided for technology research in IITs and IISc over the…

February 1, 2025 16:28 IST

Budget 2025: Health sector gets Rs 99,859 crore; allocation jumps by 9.8 percent

Budget 2025: The government has also allocated ₹2,445 crore for PLI for the pharmaceutical industry. The sector saw a 191%…

February 1, 2025 16:04 IST

Budget2025,Nirmala Sitharaman,Objectives Of Budget,36 Life-Saving Drugs,Basic Customs Duty, healthcare news, budget 2025 news,

Budget 2025: 36 life-saving drugs fully exempted from custom duty – Check full list

Budget 2025: In July last year, after the Lok Sabha elections, the Health Ministry was allocated Rs 90958.63 crore in…

February 1, 2025 13:00 IST

Budget 2025, Union Budget 2025, India Budget 2025, health Budget 2025, Budget 2025 health Announcements, health Budget 2025 Announcements, health Budget 2025 Highlights, FM Nirmala Sitharaman health Budget 2025 Announcements, healthcare news,

Health Budget 2025: Nirmala Sitharaman announces launch of 200 cancer daycare centres, promotion of medical tourism

Union Budget 2025 Health Announcements: In July last year, after the Lok Sabha elections, the Health Ministry was allocated Rs…

February 1, 2025 11:42 IST

Donald Trump, US President, reciprocal tariff, Indian economy, economic strategy, GDP growth, IMF, INR, Dollar, monetary policy

Economic Survey 2025 highlights impact of Ultra-processed junk food, U-WIN’s role in immunisation effort

The pre-budget document tabled in Parliament on Friday said that the government must focus on a multi-pronged approach with stricter…

February 1, 2025 07:14 IST

Pharmaceutical and healthcare industry could remain at the centre stage of the government’s growth agenda/ Representative Photo. (Image Source: Freepik)

Will Budget’2025 prescribe incentive dosages for India’s pharmaceutical and healthcare sector

India Inc anticipates simplified tax laws, reduced litigation, and progressive policies in Budget 2025, with the pharmaceutical and healthcare sectors…

January 31, 2025 20:49 IST

Finance Minister Niramala Sitharaman, Nirmala Sitharaman, Budget 2025, Budget 2025 expectations, Healthcare Budget 2025, pharma budget 2025, healthcare news, budget 2025 news,

Prescription for change: How Budget 2025 could impact your medical bills

By focusing on increased funding, tax incentives, and support for domestic manufacturing, the government aims to make healthcare more accessible…

January 31, 2025 20:13 IST

Rare disease patients urge PM Modi to address delay in Rs 974 crore national programme roll-out

According to the open letter, the delay in rolling out the proposed ₹ 974 crore national programme on rare diseases…

January 30, 2025 08:25 IST

Schizophrenia in India, best medicine for schizophrenia in India, prevalence of schizophrenia in India, best doctor for schizophrenia in India, prevalence of schizophrenia in India 2023, best treatment for schizophrenia in India, famous personalities with schizophrenia in India, best rehabilitation centre for schizophrenia in India, epidemiology of schizophrenia in India, how common is schizophrenia in India, case study of schizophrenia in India, mental illness in ancient India, schizophrenia and divorce in India, schizophrenia and marriage in India, is schizophrenia common in India, schizophrenia in Indian celebrities, cases of schizophrenia in India, schizophrenia in India statistics, schizophrenia treatment in India, schizophrenia in Indian culture, FDA approves schizophrenia drug in India, incidence and prevalence of schizophrenia in India, is schizophrenia a disability in India, home for schizophrenics in India, schizophrenia best treatment in India, schizophrenia best doctor in India, best schizophrenia hospital in India, best psychiatrist for schizophrenia in India, schizophrenia percentage in India, schizophrenia injection cost in India, best hospital for schizophrenia in India, best schizophrenia treatment centers in India, is schizophrenia covered by insurance in India, mental illness in Indian culture, schizophrenia rehabilitation centers in India, schizophrenia surgery cost in India, celebrities with schizophrenia in India, Indian celebrities with schizophrenia in India, mental illness in India group discussion, schizophrenia doctors in India, schizophrenia divorce rate in India, schizophrenia specialist in India, schizophrenia epidemiology in India, schizophrenia treatment cost in India, medicine for schizophrenia in India, treatment for schizophrenia in India, rehab for schizophrenia in India, best psychiatrist in India for schizophrenia, famous people with schizophrenia in India, best hospital for schizophrenia treatment in India, mental illness in India GD, schizophrenia in India vs USA, schizophrenia support group in India, schizophrenia hospital in India, how many people have schizophrenia in India, how many people suffer from schizophrenia in India, how many schizophrenia patients in India, how is schizophrenia treated in India, schizophrenia in Hindi Wikipedia, schizophrenia incidence in India, injection for schizophrenia in India, incidence of schizophrenia in India, which hospital in India is best for schizophrenia, schizophrenia in Indian law, mental illness in Indian literature, schizophrenia marriage law in India, lifetime prevalence of schizophrenia in India, schizophrenia tablets in India, living with schizophrenia in India gender perspectives, schizophrenia in Indian movies, schizophrenia in West Indian men, mental illness in West Indian men, schizophrenia doctors in Mumbai, schizophrenia operation in India, treatment of schizophrenia in India, percentage of schizophrenia in India, prevalence of schizophrenia in India 2024, prevalence of schizophrenia in India 2022, rate of schizophrenia in India, best treatment of schizophrenia in India, mental illness disability benefits in India PDF, schizophrenia pronunciation in India, schizophrenia patients in India, schizophrenia people in India, schizophrenia population in India, prevalence rate of schizophrenia in India, healthcare news, pharma news,

FE Mental Health Series | ‘My brother’s schizophrenia showed me society’s lack of support for the mentally ill’

Usually described as a splitting or multiple personality disorder, the concept of schizophrenia is not entirely but rather a disconnection…

January 30, 2025 08:08 IST

Budget 2025: Will Nirmala Sitharaman cut the cost of medicines and hospitalisation?

In Budget 2024, the government slashed GST (Goods and Services Tax) from three major cancer drugs: Trastuzumab Deruxtecan, Osimertinib and…

January 29, 2025 17:44 IST

USFDA, Ozempic, Ozempic news, Novo Nordisk, Novo Nordisk news, USFDA news, healthcare news, pharma news,

USFDA gives nod to Novo Nordisk’s Ozempic to reduce risk of kidney failure

Last month, the European Medicines Agency allowed Novo to add risk reduction for events related to kidney disease to the…

January 29, 2025 10:11 IST

multivitamins, healthcare, health, medicines, medication, vitamins, hypervitaminosis

The truth about multivitamins

There has been a lot of buzz over the regulation of dietary or nutritional supplements. But do you even need…

January 26, 2025 05:30 IST

Mankind Pharma transfers OTC Business to subsidiary Mankind Consumer Products Private Limited

Q3FY25: Mankind Pharma’s revenue up by 24 percent to Rs 3,230 Crore; Profit at Rs 380 crore

The integration of BSV is on track, with focus on mandate brands, improving productivity and adopting best practices to ensure…

January 23, 2025 19:39 IST

Dr Reddy’s Laboratories, cancer drug, Keytruda, partnership, Alvotech, biosimilar, license agreement, manufacturing

Q3FY25: Dr. Reddy’s to focus on continued CapEx investment, R&D and increasing capacity of existing portfolio

The Hyderabad-based drug major had reported a profit of Rs 1,379 crore for the October-December period of last fiscal. Revenue…

January 23, 2025 19:27 IST

Aurigene Oncology reports positive outcomes of Phase 1 trial for CAR-T cell therapy in India

Q3FY25 Results: Dr. Reddy’s Laboratories reports over 2 percent rise in profit YoY; Revenue at Rs 8358.6 crore

In the Global Generics Business, the company reported Q3FY25 revenues at Rs.7380 crore, YoY growth of 17% and QoQ growth…

January 23, 2025 17:17 IST

USFDA warning multiple sclerosis, FDA multiple sclerosis, FDA multiple sclerosis guidance, FDA-approved multiple sclerosis drugs, multiple sclerosis FDA-approved drugs, what are warning signs of multiple sclerosis, what is affected by multiple sclerosis, what are the early warning signs of multiple sclerosis, CDW multiple sclerosis, multiple sclerosis flag, multiple sclerosis red flags, early warning signs multiple sclerosis, EDSS in multiple sclerosis, exacerbation of multiple sclerosis symptoms, first warning signs of multiple sclerosis, multiple sclerosis and Gulf War veterans, multiple sclerosis gold standard diagnosis, what are the warning signs of multiple sclerosis, HS and multiple sclerosis, what are the first warning signs of multiple sclerosis, undiagnosed multiple sclerosis, is multiple sclerosis an inflammatory disease, multiple sclerosis warning signs, leflunomide multiple sclerosis, multiple sclerosis functional limitations, multiple sclerosis NFL, NEDA multiple sclerosis, O multiple sclerosis, pseudo multiple sclerosis, PML warning signs, PDDS multiple sclerosis, red flag signs of multiple sclerosis, red flags in multiple sclerosis, signs of multiple sclerosis usually begin, what are early warning signs of multiple sclerosis, warning signs multiple sclerosis, can you be misdiagnosed with multiple sclerosis, symptoms of multiple sclerosis usually begin, sulfasalazine multiple sclerosis, multiple sclerosis flare-up ICD-10, multiple sclerosis 5 facts, 7 warning signs of MS, 7 early warning signs of MS, healthcare news, pharma news,

USFDA issues warning of serious allergic reaction with multiple sclerosis drugs; Urges patients to be cautious

Patients should stop taking glatiramer acetate and seek immediate medical attention by going to an emergency room or calling 911…

January 23, 2025 12:31 IST

healthcare, health, MBBS, National Health Mission, Ayushman Bharat Pradhan Mantri Jan Arogya Yojana, PM-JAY, the National Tele Mental Health Programme

Budget and healthcare explained: Sector still waiting for the right prescription

Data shared by the government in the Rajya Sabha in December 2023 revealed that 39.2% of the faculty posts in…

January 21, 2025 02:45 IST

Related News

'We have faced a 100x increase in Arattai traffic in...,' says Zoho CEO Sridhar Vembu, Perplexity AI CEO Aravind Srinivas reacts

Perplexity CEO Aravind Srinivas congratulates Sridhar Vembu as Arattai jumps from 3,000 to 350,000 sign-ups within days of its launch

Baal Aadhaar Card update 2025 : How to apply Aadhaar Card for children below the age of 5 years in simple steps

e-Aadhaar app launch in India: Update your date of birth, address and phone number instantly with the upcoming all-in-one app

About 10 ICE agents chase food delivery worker in Chicago: Viral video captures bike escape

World’s second-richest billionaire Larry Ellison looks surprisingly young at 80; his anti-aging secrets revealed

prashant kishor, prashant kishor salary, prashant kishor income, bihar elections, bihar election, bihar election 2025, bihar polls, samrat choudhary

‘Hum chor nahi hain’: Prashant Kishor declares his income in Bihar rally, ‘earned Rs 241 cr, paid GST, tax’

Tata Capital IPO price band at 55% discount to unlisted market

Market4 hr ago

Tata Capital’s upcoming IPO has a price band of Rs 310-326 per share, much lower than its current unlisted market price of Rs 735-765. It is also 5-10% lower than the rights issue price of Rs 343 per share. The IPO is expected to raise Rs 15,512 crore and market analysts are optimistic about its success.

View all shorts